Products | Guidewires | July 28, 2015

Safari2 Pre-Shaped Guidewire

Related Content

Mike Black
News | Heart Valve Technology
CPR-Therapeutics, Inc. Names Mike Black as Chief Strategy Officer

April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...

Home April 17, 2024
Home
Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number
News | Heart Valve Technology
New Technology Promises to Revolutionize Valvular Heart Disease Care

April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...

Home April 01, 2024
Home
Study investigators Drs. Pedro Engel-Gonzalez and Gennaro Giustino from Henry Ford Health.
News | Heart Valve Technology
Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart ...

Home January 04, 2024
Home
TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, announced the successful implantation of its Topaz transfemoral tricuspid heart valve replacement system (“Topaz”) in a patient with a pacemaker at the University Medical Center of Mainz, Germany.
News | Heart Valve Technology
TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of ...

Home December 22, 2023
Home
Substance use disorder may be linked to more deaths from infective endocarditis among people ages 25-44, finds new study in Journal of the American Heart Association
News | Heart Valve Technology
Deaths from Heart Valve Infections Drop Across US Overall, but Surged Among Young Adults

December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S. within the ...

Home December 18, 2023
Home
Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of blood clots, according to a retrospective study published in Mayo Clinic Proceedings.
News | Heart Valve Technology
Use of Anticoagulant Drug after Aortic Valve Replacement Lowers Mortality Risk, Mayo Clinic Study Finds

December 12, 2023 — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement ...

Home December 12, 2023
Home
New data from the ARIES trial show for the first time that an aspirin-free regimen can improve outcomes for people living with the heart pump by reducing hospitalizations without increasing the risk of blood clots
News | Heart Valve Technology
Late-breaking Data Show an Aspirin-free Medication Regimen Benefits People with Abbott’s HeartMate 3 Heart Pump

November 20, 2023 — Abbott announced new late-breaking data that show advanced heart failure patients living with its ...

Home November 20, 2023
Home
Figure 1: A PROTECT III study analysis demonstrates that 82.5% of Impella-supported HRPCI patients have features in all three high-risk factor domains – comorbidities, complex coronary anatomy and adverse hemodynamics.
News | Heart Valve Technology
Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium

October 24, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announced that novel data from seven research studies ...

Home October 24, 2023
Home
The Patel Children's Heart Institute at St. Joseph's Children's Hospital achieved a milestone recently, implanting its 250th congenital transcatheter heart valve.
News | Heart Valve Technology
St. Joseph's Children's Hospital Implants 250th Pulmonary Valve Without Open-Heart Surgery

October 17, 2023 — The Patel Children's Heart Institute at St. Joseph's Children's Hospital achieved a milestone ...

Home October 17, 2023
Home
IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients
News | Heart Valve Technology
Minneapolis Heart Institute Foundation Launches the PROGRESS Clinical Trial to Examine the Safety and Effectiveness of Transcatheter Valve Replacement in Patients with Moderate, Calcific Aortic Stenosis

September 20, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

Home September 20, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now